Published in Gynecol Oncol on February 01, 2000
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996) 7.09
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med (1994) 6.59
Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation (2000) 4.16
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA (2000) 3.69
The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell (1992) 3.20
Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem (1994) 2.82
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol (1989) 2.71
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet (1994) 2.66
Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med (1997) 2.52
Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J (2000) 2.50
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res (1997) 2.40
Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature (1994) 2.35
Structural determinants of protein dynamics: analysis of 15N NMR relaxation measurements for main-chain and side-chain nuclei of hen egg white lysozyme. Biochemistry (1995) 2.31
Measuring outcomes: one month survival after acute myocardial infarction in Scotland. Heart (1996) 2.30
"I don't like Mondays"-day of the week of coronary heart disease deaths in Scotland: study of routinely collected data. BMJ (2000) 2.25
Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood (1988) 2.24
Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. Cell (1993) 2.20
Genetic instability of microsatellites in endometrial carcinoma. Cancer Res (1993) 2.20
Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol (2001) 2.17
Fractionation of hemagglutinating and bacterial binding adhesins of Bacteroides gingivalis. Infect Immun (1984) 1.99
Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study. Lancet (2001) 1.96
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg (1981) 1.90
A refined solution structure of hen lysozyme determined using residual dipolar coupling data. Protein Sci (2001) 1.88
Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet (1994) 1.81
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77
Specific binding of the diphtheria tox regulatory element DtxR to the tox operator requires divalent heavy metal ions and a 9-base-pair interrupted palindromic sequence. Proc Natl Acad Sci U S A (1992) 1.74
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst (1999) 1.73
Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins. Neuron (1995) 1.70
Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis. BMJ (2004) 1.68
BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. Am J Obstet Gynecol (1998) 1.68
The ICCD benchmarks for clubhouses: a practical approach to quality improvement in psychiatric rehabilitation. Psychiatr Serv (2001) 1.63
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
Predictors of recurrence in stage I (T1N0M0) breast carcinoma. Ann Surg (1981) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Paclitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol (2001) 1.59
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol (1989) 1.57
Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential. Gynecol Oncol (1995) 1.54
Integrated model for providing tactical emergency medicine support (TEMS): analysis of 120 tactical situations. Acta Anaesthesiol Scand (2011) 1.51
Chronic simple bronchitis in pigeon fanciers. Relationship of cough with expectoration to avian exposure and pigeon breeders' disease. Chest (1989) 1.51
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathol (1993) 1.50
Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer (1994) 1.50
Short selective pulses for biochemical applications. J Magn Reson B (1995) 1.49
High-resolution 1H NMR study of the solution structure of alamethicin. Biochemistry (1987) 1.49
Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer (1996) 1.48
Isolation of poly-alpha-L-guluronate lyase from Klebsiella aerogenes. Carbohydr Res (1977) 1.46
The lagged effect of cold temperature and wind chill on cardiorespiratory mortality in Scotland. Occup Environ Med (2005) 1.45
Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Obstet Gynecol (1988) 1.45
Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol (2001) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer (2000) 1.41
The Clq receptor site on immunoglobulin G. Nature (1980) 1.40
p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol (1996) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat (1999) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer. Int J Cancer (1996) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res (1996) 1.32
Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer (2003) 1.32
Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair. Nat Genet (1996) 1.28
Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. BMJ (2001) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer (2000) 1.24
Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein. Proc Natl Acad Sci U S A (1986) 1.23
Natural and anthropogenic inputs of hydrocarbons to the Strait of Georgia. Sci Total Environ (1999) 1.23
A highly informative X-chromosome probe, M27 beta, can be used for the determination of tumour clonality. Br J Haematol (1990) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Sleeping sickness. The Castellani-Bruce controversy. Notes Rec R Soc Lond (1973) 1.19
Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol (2000) 1.19
Dinucleotide repeat polymorphism in the human DCC gene at chromosome 18q21. Hum Mol Genet (1992) 1.18
Chest physiotherapy in the neonate: a controlled study. Pediatrics (1978) 1.17
Prognosis in stage II (T1N1M0) breast cancer. Ann Surg (1981) 1.16
Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res (1999) 1.16
The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol (1994) 1.16
In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens. Antimicrob Agents Chemother (1986) 1.16
Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. Cancer Res (1997) 1.16
Secondary structure of human interleukin 2 from 3D heteronuclear NMR experiments. Biochemistry (1992) 1.15
The genetic organization of the mau gene cluster of the facultative autotroph Paracoccus denitrificans. Biochem Biophys Res Commun (1992) 1.15
Human interleukin 4. The solution structure of a four-helix bundle protein. J Mol Biol (1992) 1.14
Hereditary breast cancer. Curr Probl Surg (2001) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Al+++ binding studies and metallic cation effects on bioprosthetic heart valve calcification in the rat subdermal model. ASAIO Trans (1990) 1.13
The hairpin structure of the (6)F1(1)F2(2)F2 fragment from human fibronectin enhances gelatin binding. EMBO J (2001) 1.13
Mucin production in medullary carcinoma of the thyroid. Arch Pathol Lab Med (1983) 1.13
The solution conformations of the subclasses of human IgG deduced from sedimentation and small angle X-ray scattering studies. Mol Immunol (1987) 1.12
The search for BRCA1. Cancer Res (1994) 1.11
1H NMR assignment and secondary structure of the cell adhesion type III module of fibronectin. Biochemistry (1992) 1.11
Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. Cancer Res (1998) 1.10
The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol Oncol (1997) 1.10
Analysis of multiple casualty incidents - a prospective cohort study. Acta Anaesthesiol Scand (2005) 1.09
Experimental evaluation of a phakic anterior chamber implant in a primate model. Part II. Pathology. J Cataract Refract Surg (1991) 1.09
Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194. J Biol Chem (1990) 1.08
Treatment of endometrial stromal tumors. Gynecol Oncol (1990) 1.08